Core Viewpoint - Giant Medical Holdings (02393) is considering establishing a joint venture with New Genetron Holding Limited in Singapore, focusing on advanced molecular diagnostics in oncology, particularly in Indonesia, Malaysia, and Singapore [1] Group 1: Company Developments - On October 20, Giant Medical Holdings announced plans for a joint venture that will involve setting up a new entity in Indonesia dedicated to designing, constructing, and operating clinical molecular diagnostic laboratories focused on precision oncology [1] - The proposed joint venture aims to provide advanced gene testing, including cancer screening, to assist doctors in early disease detection and tailor treatment plans for patients [1] Group 2: Industry Focus - The joint venture will concentrate on advanced molecular diagnostic services, utilizing cutting-edge laboratory tests to detect and understand diseases at the molecular level, particularly in the field of precision oncology [1] - The initiative is expected to establish in vitro diagnostic reagent and kit production facilities in Indonesia when appropriate, enhancing local healthcare capabilities [1]